Around 1.4 million people in the UK have been diagnosed with Chronic Obstructive Pulmonary Disease (COPD) and with around another 2 million people thought to have undiagnosed COPD, COPD is considered to be the 2nd most common lung disease in the UK (NHS).
COPD exacerbations are the 2nd biggest cause of emergency hospital admissions in the UK, which is why research into new and evolving treatments for COPD is so important.
We’re looking for patients who are living with COPD to register their interest in these clinical trials. Interested in finding out more about these clinical trials? Please leave your contact details to allow our team to get in touch with you to explain more about the clinical trials and how you can participate
These clinical trials are open to those participants who may:
- Have been diagnosed with COPD
- Have a history of smoking
- Have experienced COPD exacerbations
Your participation in these clinical trials will involve receiving the trial treatments, or placebos, throughout the trial durations. Your participation in clinical trials will also involve regular visits to your local FutureMeds clinic throughout the course of the trials
Participants in these clinical trials may also receive reimbursement for their trial related time and activities, such as visits to our clinic
Participation in clinical trials provides access to innovative and potentially life-saving treatments. It also contributes to medical research, benefiting both current and future healthcare outcomes. It provides cutting-edge medical care under professional supervision and empowers individuals to contribute to the well-being of society. However, participants should carefully weigh up the risks and benefits and seek advice from their doctor before taking part in a trial.
